COMMUNIQUÉS West-GlobeNewswire

Forward Pharma to Participate in the Nordic-American Life Science Conference
09/11/2017
COPENHAGEN, Denmark, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ: FWP ) (the “Company”) today announced that Dr. Claus Bo Svendsen, the Company’s Chief Executive Officer, will participate in the Nordic- [...]
PLx Pharma Inc. Reports Third Quarter 2017 Results
09/11/2017
HOUSTON, Nov. 09, 2017 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP ) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected products, Aspertec™ 325 [...]
Aptevo Therapeutics Reports Third Quarter 2017 Financial Results
09/11/2017
Strengthened Cash Position to Support Ongoing R&D and Commercial Activities; Reported $107 Million in Cash at the End of the Third Quarter Expanded Novel Bispecific Antibody Portfolio Through Collaboration with [...]
Dyadic International Reports Third Quarter 2017 Financial Results
09/11/2017
JUPITER, Fla., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform [...]
Galena Biopharma Reports Third Quarter 2017 Financial Results
09/11/2017
SAN RAMON, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ: GALE ), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical needs, today reported [...]
Kura Oncology to Host Investor Day on November 16, 2017
09/11/2017
SAN DIEGO, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Kura Oncology, Inc., (Nasdaq: KURA ) a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that it will [...]
Fortress Biotech Reports Third Quarter 2017 Financial Results and Recent Corporate Highlights
09/11/2017
NEW YORK, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO ) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology [...]
ICU Medical, Inc. Announces Third Quarter 2017 Results
09/11/2017
SAN CLEMENTE, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI ), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care [...]
Ovid Therapeutics Reports Third Quarter 2017 Financial Results and Corporate Progress
09/11/2017
NEW YORK, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID ), a biopharmaceutical company committed to developing medicines for patients with rare neurological diseases, today announced financial [...]
Cyclacel Pharmaceuticals Reports Third Quarter 2017 Financial Results
09/11/2017
BERKELEY HEIGHTS, N.J., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC ) (NASDAQ: CYCCP ) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral therapies that target [...]
Zosano Pharma Reports Third Quarter 2017 Financial Results and Operational Update
09/11/2017
First patient enrolled in long term safety study in November 2017 Phase 2/3 data presented at International Headache Society in September Clinical results published in two leading scientific journals Access to capital [...]
Yield10 Bioscience Announces Third Quarter 2017 Financial Results
09/11/2017
WOBURN, Mass., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) today reported financial results for the three and nine months ended September 30, 2017. “Over the course of 2017 we have focused [...]
CareDx Reports Third Quarter 2017 Financial Results
09/11/2017
BRISBANE, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ: CDNA ), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value [...]
Avinger Announces Third Quarter 2017 Results
09/11/2017
REDWOOD CITY, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ: AVGR ) (“Avinger” or the “Company”), a leading developer of innovative treatments for peripheral artery disease (PAD), today reported [...]
Altimmune Announces Third Quarter 2017 Financial Results and Provides Corporate Update
09/11/2017
Initiated a Phase 2 clinical trial with NasoVAX vaccine with initial data expected in first quarter 2018 Completed enrollment in its Phase 1 HepTcell clinical trial with data expected in fourth quarter 2017 Conference [...]
Stemline Therapeutics Reports Third Quarter 2017 Financial Results
09/11/2017
NEW YORK, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML ), a clinical-stage biopharmaceutical company developing novel therapeutics for difficult to treat cancers, announced today financial [...]
Endocyte to Present at the Jefferies 2017 London Healthcare Conference
09/11/2017
WEST LAFAYETTE, Ind., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ: ECYT ), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced that the company’s [...]
Cellectar Biosciences Reports Third Quarter 2017 Financial and Corporate Performance
09/11/2017
MADISON, Wis., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB ), an oncology-focused, clinical stage biotechnology company (the “company”), today reported financial results and corporate [...]
Mersana Announces Third Quarter 2017 Financial Results and Provides Business Updates
09/11/2017
Received FDA Clearance of IND Application for XMT-1536, a First-in-Class Dolaflexin® Antibody Drug Conjugate Targeting NaPi2b XMT-1522 Phase 1 Trial Continues Enrollment of Patients with Advanced Tumors Expressing HER2 [...]

Pages